 |
 Video: What is a Stock Split?
|
|
|
| ImmuCell is an animal health company. Co. focuses on creating products that improve the health and productivity of dairy and beef cattle. The First Defense® product line provides bovine antibodies that newborn calves need but are unable to produce on their own immediately after birth. The target disease, calf scours (bovine enteritis), causes diarrhea and dehydration in newborn calves and often leads to serious sickness and even death. The First Defense® product line is an orally delivered scours preventive product on the market for calves with claims against E. coli, coronavirus and rotavirus. Co.'s Beyond Vaccination® marketing campaign focuses on providing antibodies without vaccination. According to our ImmuCell stock split history records, ImmuCell has had 2 splits. | |
|
ImmuCell (ICCC) has 2 splits in our ImmuCell stock split history database. The first split for ICCC took place on July 24, 1990. ICCC's second split took place on July 25, 1990. This was a 1 for 100 reverse split, meaning for each 100 shares of ICCC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 10 share position following the split.
When a company such as ImmuCell conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ImmuCell stock split history from start to finish, an original position size of 1000 shares would have turned into 10 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ImmuCell shares, starting with a $10,000 purchase of ICCC, presented on a split-history-adjusted basis factoring in the complete ImmuCell stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$4.42 |
|
| End price/share: |
$5.05 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
14.25% |
|
| Average Annual Total Return: |
1.34% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$11,423.34 |
|
| Years: |
10.00 |
|
|
|
| Date |
Ratio |
| 07/24/1990 | 1 for 1 | | 07/25/1990 | 1 for 100 |
|
|
Free ICCC Email Alerts:
